Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 3/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.33 |
| ▸ | SELE | P16581 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CFTR | P13569 | 3/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17403693 | 1.00 | CTSD (0.35) | CTSDNAAAICAM1SELECNR2 | |
| SCHEMBL17955660 | 0.93 | CNR2 (0.33) | CTSDCNR2 | |
| SCHEMBL17403697 | 0.87 | NPBWR1 (0.38) | ICAM1SELENPBWR1 | |
| SCHEMBL17403699 | 0.87 | NPBWR1 (0.38) | ICAM1SELENPBWR1 | |
| SCHEMBL16786426 | 0.83 | RORA (0.39) | ICAM1SELENPBWR1ALDH1A1 | |
| SCHEMBL16786442 | 0.82 | RORA (0.38) | ICAM1SELENPBWR1ALDH1A1 | |
| SCHEMBL16786443 | 0.82 | RORA (0.38) | ICAM1SELENPBWR1ALDH1A1 | |
| SCHEMBL16786425 | 0.82 | RORA (0.38) | ICAM1SELENPBWR1ALDH1A1 | |
| SCHEMBL17190547 | 0.81 | MEN1 (0.41) | ICAM1SELEALDH1A1 | |
| SCHEMBL17403692 | 0.81 | ICAM1 (0.33) | ICAM1SELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160002238-A1 | COMPOUND, SOLAR CELL MODULE, AND PHOTOVOLTAIC POWER GENERATION DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2016-01-07 | — | — | US | disclosed |
| US-20160002238-A1 | COMPOUND, SOLAR CELL MODULE, AND PHOTOVOLTAIC POWER GENERATION DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2016-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002238-A1 | COMPOUND, SOLAR CELL MODULE, AND PHOTOVOLTAIC POWER GENERATION DEVICE | CRY1, CCNE2, CCND2 | CTSD 4153/4885NAAA 4139/4885ICAM1 3807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.